MedTrace Logo

Postoperative Pain in Scheduled Craniotomy

NCT04720248 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 73

Last updated 2021-08-18

No results posted yet for this study

Summary

Postoperative pain after craniotomy is frequent, with moderate-severe intensity. The fear to the side effects of opioids (nausea and vomiting and sedation), and NSAIDs (bleeding) makes it difficult to obtain adequate analgesic control in these patients. Preoperative anxiety may be associated with a poorer postoperative analgesic control, hindering the adequate postoperative evolution and increasing hospital stay and adverse effects. In this observational study, the investigators aimed to assess the postoperative analgesic management in patients undergoing scheduled craniotomy following routine clinical practice and to relate preoperative anxiety with the postoperative analgesic evaluation in this population.

Conditions

  • Pain, Postoperative
  • Craniotomy
  • Adverse Effect
  • Anxiety

Interventions

DRUG

Metamizole

Patients will receive metamizole intraoperatively and throughout 48h postoperatively.

Sponsors & Collaborators

  • Dr. Negrin University Hospital

    lead OTHER

Principal Investigators

  • Aurelio Rodríguez Pérez, PhD · Hospital Universitario de Gran Canaria Doctor Negrín

  • Ángel Becerra, MD · Hospital Universitario de Gran Canaria Doctor Negrín

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-24
Primary Completion
2021-06-30
Completion
2021-08-15
FDA Drug
Yes

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04720248 on ClinicalTrials.gov